Morbidity and Mortality Weekly Report 2013-02-15

Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase--Denver, Colorado, 2012.

Index: MMWR Morb. Mortal. Wkly. Rep. 62(6) , 108, (2013)

Full Text: HTML

Abstract

On August 16, 2012, the Colorado Department of Public Health and Environment was notified of two patients at an acute-care hospital in Denver with carbapenem-resistant Enterobacteriaceae (CRE), specifically Klebsiella pneumoniae (CRKP), isolated from respiratory specimens during July-August. Both isolates produced New Delhi metallo-beta-lactamase (NDM). A review of microbiology records identified a third patient with NDM-producing CRKP isolated from a respiratory specimen, admitted in May. Active surveillance cultures in September identified an additional five patients colonized with NDM-producing CRKP. An investigation was launched by the hospital and the Colorado Department of Public Health and Environment to guide infection control measures and limit transmission.

Related Compounds

  • β-LactaMase

Related Articles:

A Novel Microbisporicin Producer Identified by Early Dereplication during Lantibiotic Screening.

2015-01-01

[Biomed Res. Int. 2015 , 419383, (2015)]

Identification of peptide inhibitors of penicillinase using a phage display library.

2016-02-01

[Anal. Biochem. 494 , 4-9, (2015)]

Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.

2014-03-01

[J. Med. Microbiol. 63(Pt 3) , 386-92, (2014)]

Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.

2012-11-01

[J. Assoc. Physicians India 60 , 22-4, (2012)]

Looking for the new preparations for antibacterial therapy. II. Clinical trials; new beta-lactam antibiotics and beta-lactamase inhibitors.

2013-01-01

[Przegl. Epidemiol. 67(1) , 51-6, 135-40, (2013)]

More Articles...